Programs
Programs
AIM-HI leverages its positioning within the scientific and entrepreneurial communities to identify promising startups for investment. We consistently support companies led by best-in-class scientist-entrepreneurs around the globe.
In doing so, we challenge the status quo, in which only a small percentage of such companies ever make it into commercial ventures.
We measure the success of our investments not only in fiscal return, but in patient lives saved.
Please click on each company to read more of their story.
Stories From Our Companies
Enhancing surgery and diagnostics with unique, cancer-targeted molecular probes to improve outcomes and patients’ quality of life
Chimera Bio
Arming CAR-Ts with immunomodulatory payloads to counteract the tumor microenvironment, enabling CAR-T efficacy in solid tumors
A breakthrough therapy for lethal cancers by deploying novel Cancer Terminator Viruses
Unique target and small molecules to treat different stages of cancer progression
ManaT Bio
A pre-clinical biotech company developing precision immunotherapies targeting the most common cancer-causing mutations
Discovering, developing, and commercializing more effective and less toxic therapies for pediatric oncology
Localized cancer therapy for a more potent and significantly safer treatment
Harnessing the power of computational drug design for the identification of novel cancer therapeutics
A Specialty Pharmaceutical Company Advancing Cancer Treatment Through Safer Drug Delivery
Developing potential breakthrough therapies for patients with cancer by targeting cancer-specific vulnerabilities & co-dependencies in the tumor microenvironment
Targeting unique cancer-specific antigens using powerful antibody-drug-conjugates to deliver a lethal blow to cancer
Developing oral inhibitors of STAT3 as breakthrough therapies for cancer and fibrosis
Discovering and developing transformational therapeutics to address critical unmet patient needs in life-threatening diseases.
Supporting Women Entrepreneurs in STEM with Social Impact Funding
AIM-HI is on a mission to transform the non-profit impact investment landscape and break the barriers that hold back women-led STEM innovations. We envision a new paradigm of philanthropy that empowers millions of lives with a powerful Impact and a high-potential upside. We recognize the value of women’s perspective in developing cutting-edge STEM technologies that can solve the world’s most pressing challenges. Women-led companies are not only faster to deliver results, but also generate higher revenues. Yet, they face a huge funding gap, receiving only 3% of VC financing and 1/3 less loans than male-owned companies. This is unacceptable, and we are here to change it!
I especially like the antifraud features of AngeLink. Secondly, I also believe in empowering women who can amplify the impact on family, community, and business. And the third thing is I think this will be a great platform to support some of our research breakthroughs. So, for me, it’s really a win, win, win!”
-Sujuan Ba, Ph.D., AIM-HI CEO & Co-Founder
The world’s first Social Fintech platform powered by women, open to all.
Why Support AIM-HI
An IRS-Approved Vehicle to Maximize Tax-Deductions & Make Direct Impact Investments in Mission-Based Companies
- Enables donors, foundations and nonprofits the opportunity to fund social impact, for-profit companies with tax-deductible dollars.
- Advance charitable mission beyond grant-making.
- Partner with leading research institutions to support early-stage STEM and social impact entrepreneurs.
Benefits:
- Income Tax Reduction and Capital Gains Mitigation
- Minimize Major Tax Event and Estate Tax
- Unlock Future Financing for Social Initiatives
- Recycling Philanthropic Capital to Magnify Social Impact
- Improved Sustainability of Social Enterprises
Summer Entrepreneurship Fellowship for Future Healthcare Leaders
The AIM-HI Accelerator Fund is joining forces with Georgetown Entrepreneurship to offer a 2025 Summer Fellowship Program for those passionate about pursuing a career in healthcare entrepreneurship, particularly in oncology. During this immersive learning opportunity, fellows will work closely with our portfolio companies and gain insights into how biotech companies are funded and the drug development process.
Program Highlights
Who Should Apply
Self-motivated and fast-learning individuals with a strong interest in becoming an entrepreneur but unsure of how/where to start, and able to commit primarily on-site during the summer program.
